- Home
- DMA vs ZYXI Comparison
DMA vs ZYXI Comparison
Compare DMA & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DMA
- ZYXI
- Stock Information
- Founded
- DMA 2011
- ZYXI 1996
- Country
- DMA United States
- ZYXI United States
- Employees
- DMA N/A
- ZYXI N/A
- Industry
- DMA Trusts Except Educational Religious and Charitable
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- DMA Finance
- ZYXI Health Care
- Exchange
- DMA Nasdaq
- ZYXI Nasdaq
- Market Cap
- DMA 77.8M
- ZYXI 72.3M
- IPO Year
- DMA N/A
- ZYXI N/A
- Fundamental
- Price
- DMA $8.59
- ZYXI $2.56
- Analyst Decision
- DMA
- ZYXI Buy
- Analyst Count
- DMA 0
- ZYXI 3
- Target Price
- DMA N/A
- ZYXI $5.50
- AVG Volume (30 Days)
- DMA 34.6K
- ZYXI 136.7K
- Earning Date
- DMA 01-01-0001
- ZYXI 07-31-2025
- Dividend Yield
- DMA 2.04%
- ZYXI N/A
- EPS Growth
- DMA N/A
- ZYXI N/A
- EPS
- DMA N/A
- ZYXI N/A
- Revenue
- DMA N/A
- ZYXI $172,401,000.00
- Revenue This Year
- DMA N/A
- ZYXI N/A
- Revenue Next Year
- DMA N/A
- ZYXI $19.55
- P/E Ratio
- DMA N/A
- ZYXI N/A
- Revenue Growth
- DMA N/A
- ZYXI N/A
- 52 Week Low
- DMA $4.78
- ZYXI $1.66
- 52 Week High
- DMA $8.00
- ZYXI $9.42
- Technical
- Relative Strength Index (RSI)
- DMA 45.61
- ZYXI 57.84
- Support Level
- DMA $8.44
- ZYXI $2.46
- Resistance Level
- DMA $8.71
- ZYXI $2.82
- Average True Range (ATR)
- DMA 0.11
- ZYXI 0.15
- MACD
- DMA -0.02
- ZYXI 0.02
- Stochastic Oscillator
- DMA 43.66
- ZYXI 66.23
About DMA Destra Multi-Alternative Fund
Destra Multi-Alternative Fund is a non-diversified, closed-end management investment company that operates as an interval fund with a continuous offering of fund shares. The investment objective of the fund is to seek returns from capital appreciation and income with an emphasis on income generation.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.